Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction (MI), ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Early data in mice and human tissue indicate that using drugs or gene therapy could allow for cardiac healing in ischemic HF.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

Exercise is essential for heart health, but there is a risk of heart attacks during vigorous workouts, especially for those with existing conditions.

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...

Comorbid lung function impairment was associated with increased risks for cardiovascular disease and mortality in type 2 diabetes.

LncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...